⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

CR
Canara Robeco MFCanara Robeco Mid Cap Fund - Growth - Direct PlanDirect · Growth
₹18.04 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricCRCanara Robeco Mid Cap Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMCCanara Robeco MFHDFC MF
CategoryEquity - Mid Cap FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹18.04 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★
BenchmarkBSE 150 MidCap - TRIBSE Health Care - TRI
Fund ManagerPranav GokhaleNikhil Mathur
Inception02 Dec 202204 Oct 2023
Returns
1Y-1.30%22.64%
3Y15.85%30.41%
5Y——
Since Inception16.60%29.15%
Risk
16.4414.07
0.970.59
0.651.59
3.3721.67
1.263.48
-11.14%-9.23%
Costs
Expense Ratio0.86%1.03%
Exit Load1% on or before 365D, Nil after 365D1% on or before 30D, Nil after 30D
Min SIP₹1,000₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Canara Robeco…97%
HDFC MF97%
2.6%

Only 2.6% of holdings by weight are common between Canara Robeco MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Common holdingCanara Robeco MFHDFC MF
Global Health Ltd.2.56%2.72%

Category context: Equity vs Equity. Open the full Screener →